# Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis

> **NCT00354510** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 190 (—)

## Conditions studied

- Atopic Dermatitis
- Dermatitis, Atopic

## Interventions

- **DRUG:** GW842470X cream

## Key facts

- **NCT ID:** NCT00354510
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 190 (—)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354510, "Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00354510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*